Editorial Commentary
Olverembatinib for the treatment of chronic myeloid leukemia in chronic phase
Annals of Blood
2024;
9:
27
(30 September 2024)
Brief Report
Limited potential of sheep as a large animal to model transfusion-related acute lung injury mediated by antibodies against human neutrophil antigen 3a
Annals of Blood
2024;
9:
26
(30 September 2024)
Review Article
Advancing through challenges: current strategies in sickle cell disease management
Annals of Blood
2024;
9:
25
(30 September 2024)
Original Article
Predictive Model of variable laboratory findings calculation and monitoring during plasmapheresis procedures
Annals of Blood
2024;
9:
24
(30 September 2024)
Original Article
Immune thrombocytopenia exacerbation post COVID-19 vaccination: a systematic review and meta-analysis
Annals of Blood
2024;
9:
23
(30 September 2024)
Editorial
Preface to the special series “Blood Transfusion Practice in ECMO Patients”
Annals of Blood
2024;
9:
22
(30 September 2024)
Editorial
RH alleles: historical milestones, molecular advances, and clinical application
Annals of Blood
2024;
9:
21
(30 September 2024)
Letter to the Editor
Bacterial culture of platelets with large volume delayed sampling
Annals of Blood
2024;
9:
20
(30 June 2024)
Letter to the Editor
Rh D-positive genotypes in Brazilian blood donors with D-negative phenotype
Annals of Blood
2024;
9:
19
(30 June 2024)
Case Report
Blinatumomab as frontline therapy for B-cell precursor acute lymphoblastic leukemia in a critically ill young adult: a case report
Annals of Blood
2024;
9:
18
(30 June 2024)
Review Article
The “sticky platelet syndrome”: thirty years after its identification in Mexico
Annals of Blood
2024;
9:
17
(30 June 2024)
Review Article
The history of thrombotic thrombocytopenic purpura research: a narrative review
Annals of Blood
2024;
9:
16
(30 June 2024)
Review Article
The history of transfusion related acute lung injury: how we got to where we are today
Annals of Blood
2024;
9:
15
(30 June 2024)
Review Article
Coagulation management in patients requiring extracorporeal membrane oxygenation support: a comprehensive narrative review
Annals of Blood
2024;
9:
14
(30 June 2024)
Original Article
Intravenous immunoglobulin can induce antibody-dependent cell-mediated cytotoxicity and upregulate FCGR3A and FcγRIIIA expression in vitro
Annals of Blood
2024;
9:
13
(30 June 2024)
Editorial
Introductory preface for the special series “sticky platelet syndrome”
Annals of Blood
2024;
9:
12
(30 June 2024)
Editorial
Introductory comments about the special series of thrombotic microangiopathy
Annals of Blood
2024;
9:
11
(30 June 2024)
Editorial Commentary
Sticky platelet syndrome—diagnostic issues and controversies
Annals of Blood
2024;
9:
10
(30 March 2024)
Review Article
Current practice optimization suggestions and future perspectives on transfusion in patients supported by extracorporeal membrane oxygenation: a narrative review
Annals of Blood
2024;
9:
9
(30 March 2024)
Review Article
Blood products other than packed red blood cells in extracorporeal membrane oxygenation: guidelines, local protocols, and outcomes—a narrative review
Annals of Blood
2024;
9:
8
(30 March 2024)
Review Article
Patient blood management, past, present and future
Annals of Blood
2024;
9:
7
(30 March 2024)
Review Article
Economics of patient blood management in the United States: a narrative review
Annals of Blood
2024;
9:
6
(30 March 2024)
Review Article
Management of chronic myeloid leukemia (CML) in pregnant women: a comprehensive literature review
Annals of Blood
2024;
9:
5
(30 March 2024)
Review Article
Challenges with assigning RH alleles and accurately predicting phenotypes using commercially-available genotyping kits: a narrative review
Annals of Blood
2024;
9:
4
(30 March 2024)
Original Article
Immune-mediated thrombotic thrombocytopenic purpura landscaping in Gulf countries: a real-world evidence study (ATHENA Study)
Annals of Blood
2024;
9:
3
(30 March 2024)